Copy Link Print Information

Human IgG4 (S228P) kappa, Isotype Control

11 Cited Publications
Customer Review

Based on 11 publication(s) in Google Scholar

Human IgG4 (S228P) kappa, Isotype Control, a human-derived monoclonal antibody, is an isotype control for human IgG4κ antibody.

For research use only. We do not sell to patients.

  • Purity: 99.35%
  • Molecular Weight:142.35 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Human IgG4 (S228P) kappa, Isotype Control
  • Experimental Validation Results for Human IgG4 (S228P) kappa, Isotype Control
  • Experimental Validation Results for Human IgG4 (S228P) kappa, Isotype Control
  • Experimental Validation Results for Human IgG4 (S228P) kappa, Isotype Control
  • Experimental Validation Results for Human IgG4 (S228P) kappa, Isotype Control
  • Human IgG4 (S228P) kappa, Isotype Control Chemical Structure
    Human IgG4 (S228P) kappa, Isotype Control Chemical Structure
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Human IgG4 (S228P) kappa, Isotype Control Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Human IgG4 (S228P) kappa, Isotype Control

More
Customer Validation & Images
Cell Proliferation/Viability AssayCell Imaging/StainingIn Vivo Efficacy StudyRT-PCR2D/3D Cell Culture and Differentiation
  • In Vivo Efficacy Study
  • Cell Proliferation/Viability Assay
  • Cell Imaging/Staining
  • RT-PCR
  • 2D/3D Cell Culture and Differentiation
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG4 (S228P) kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: bioRxiv. 2025 Nov 24.

    Customer Validation
     Isotype control antibodies (IgG4κ and IgG1κ) were used as negative controls to demonstrate that pembrolizumab (anti-PD-1) and fragifilimab (anti-GITR) showed no inhibition of tumor growth in the HU-CD34+ T188 PDOX mouse model.

  • 1/16

    Human IgG4 (S228P) kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Aug 7;15(1):6726. [Abstract]

    Customer Validation
     An isotype control antibody (IgG4, κ, solid circles, 0–80 µg/ml, 25 h) was used as a negative control to demonstrate that the dose-dependent blockade of SHFV infection in MA-104 cells was specifically mediated by orilanolimab (open circles).

  • 1/16

    Human IgG4 (S228P) kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Aug 7;15(1):6726. [Abstract]

    Customer Validation
     Human IgG4 (S228P) kappa isotype control (80 µg/ml, 24h) was used as a negative control to demonstrate that the blockade of SHFV infection was specifically mediated by orilanolimab across multiple cell types, including uninfected cells, wild-type MA-104 cells, ACHN+hCD163 cells, and macaque iPSC-derived macrophages.

  • 1/16

    Human IgG4 (S228P) kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Aug 7;15(1):6726. [Abstract]

    Customer Validation
     Human IgG4 (S228P) kappa isotype control (80 µg/ml, 24 h) was used as a negative control to demonstrate that orilanolimab reduced the replication of SHFV, KRCV-1, and PBJV.

  • 1/16

    Human IgG4 (S228P) kappa, Isotype Control purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Aug 7;15(1):6726. [Abstract]

    Customer Validation
     Human IgG4 (S228P) kappa isotype control (80 µg/ml, 24 h) was used as a negative control to demonstrate that orilanolimab enhanced the overall survivability of macaque iPSC-derived macrophages in the presence of arteriviruses.

  • Human IgG4 (S228P) kappa, Isotype Control Chemical Structure
    1/16
  • Human IgG4 (S228P) kappa, Isotype Control